These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17675460)

  • 1. Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3+ CD4 T cells.
    Chen X; Jensen PE
    J Immunol; 2007 Aug; 179(4):2046-50. PubMed ID: 17675460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
    Shen X; Niu C; König R
    Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble MHC-II proteins promote suppressive activity in CD4+ T cells.
    Bakela K; Kountourakis N; Aivaliotis M; Athanassakis I
    Immunology; 2015 Jan; 144(1):158-69. PubMed ID: 25053509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen, in the presence of TGF-beta, induces up-regulation of FoxP3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses.
    Kapp JA; Honjo K; Kapp LM; Goldsmith K; Bucy RP
    J Immunol; 2007 Aug; 179(4):2105-14. PubMed ID: 17675469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXP3 induced by CD28/B7 interaction regulates CD25 and anergic phenotype in human CD4+CD25- T lymphocytes.
    Scottà C; Soligo M; Camperio C; Piccolella E
    J Immunol; 2008 Jul; 181(2):1025-33. PubMed ID: 18606654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells and B cells cooperate in the generation of CD4(+)CD25(+)FOXP3(+) allogeneic T cells.
    Moore C; Sauma D; Reyes PA; Morales J; Rosemblatt M; Bono MR; Fierro JA
    Transplant Proc; 2010; 42(1):371-5. PubMed ID: 20172352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
    Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
    J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.
    Turner MS; Kane LP; Morel PA
    J Immunol; 2009 Oct; 183(8):4895-903. PubMed ID: 19801514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional adaptive CD4 Foxp3 T cells develop in MHC class II-deficient mice.
    Bochtler P; Wahl C; Schirmbeck R; Reimann J
    J Immunol; 2006 Dec; 177(12):8307-14. PubMed ID: 17142726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells.
    Matsumura Y; Kobayashi T; Ichiyama K; Yoshida R; Hashimoto M; Takimoto T; Tanaka K; Chinen T; Shichita T; Wyss-Coray T; Sato K; Yoshimura A
    J Immunol; 2007 Aug; 179(4):2170-9. PubMed ID: 17675476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defects in the Bcl-2-regulated apoptotic pathway lead to preferential increase of CD25 low Foxp3+ anergic CD4+ T cells.
    Zhan Y; Zhang Y; Gray D; Carrington EM; Bouillet P; Ko HJ; O'Reilly L; Wicks IP; Strasser A; Lew AM
    J Immunol; 2011 Aug; 187(4):1566-77. PubMed ID: 21742968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal development and activation but altered cytokine production of Fyn-deficient CD4+ T cells.
    Mamchak AA; Sullivan BM; Hou B; Lee LM; Gilden JK; Krummel MF; Locksley RM; DeFranco AL
    J Immunol; 2008 Oct; 181(8):5374-85. PubMed ID: 18832694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of CD25-positive T cells during syngeneic pregnancy: production of stimulatory class II MHC molecules.
    Kyvelidou C; Chatzi K; Semitekolou M; Papathanassiou X; Vassiliadis S; Athanassakis I
    Scand J Immunol; 2009 Dec; 70(6):584-95. PubMed ID: 19906201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural and induced T CD4+CD25+FOXP3+ regulatory T cells.
    Chatenoud L
    Methods Mol Biol; 2011; 677():3-13. PubMed ID: 20941599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunoregulatory role of CD4⁺ FoxP3⁺ CD25⁻ regulatory T cells in lungs of mice infected with Bordetella pertussis.
    Coleman MM; Finlay CM; Moran B; Keane J; Dunne PJ; Mills KH
    FEMS Immunol Med Microbiol; 2012 Apr; 64(3):413-24. PubMed ID: 22211712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis.
    Turley DM; Miller SD
    J Immunol; 2007 Feb; 178(4):2212-20. PubMed ID: 17277126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
    Yamazaki S; Inaba K; Tarbell KV; Steinman RM
    Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.